1. Introduction {#sec1-ijms-17-01409}
===============

Traditional Chinese medicine (TCM) prescriptions, usually made up of several medicinal herbals according to certain mass ratios guided by traditional Chinese medicine theory, have been used for centuries for the treatment of disorders or diseases in ancient and modern China \[[@B1-ijms-17-01409],[@B2-ijms-17-01409],[@B3-ijms-17-01409]\]. It is well-accepted that a great deal of complex ingredients exist in compound Chinese traditional medicine (CCTM) and are effective through their preventive, therapeutic and synergistic effects \[[@B4-ijms-17-01409],[@B5-ijms-17-01409]\]. Furthermore, the efficacy of a CCTM does not simply equal the sum of the efficacies of all active components \[[@B6-ijms-17-01409],[@B7-ijms-17-01409]\]. Therefore, for the sake of investigating the material basis of the preventive and therapeutic effects of CCTM, it is crucial and necessary for us to make the absorbed constituents and metabolites clear in CCTM.

Guizhi decoction (GZD) is a common TCM formula composed of Ramulus Cinnamomi, Radix Paeoniae Alba, Radix Glycyrrhizae, Fructus Jujubae and Rhizoma Zingiberis Recens, which was recorded in a classic clinical TCM book titled Shanghan Lun (Treatise on Febrile Diseases) \[[@B8-ijms-17-01409]\]. In the clinic, GZD is widely used in different systems of the body, including circulation, immunity, procreation, endocrine, digestion, nerves, etc. \[[@B9-ijms-17-01409]\]. Modern pharmacological researches and the clinic experience have proved that GZD usually serve as antibacterial, analgesic, anti-anaphylaxis and antipyretic therapy as well as for the adjustment of enterokinesia, immune function, blood pressure and cardiac autonomic nervous balance \[[@B10-ijms-17-01409],[@B11-ijms-17-01409],[@B12-ijms-17-01409]\]. However, up to now, there has been little reference to the absorbed components and metabolic compounds of GZD in the literature. Research on the Rhizoma Zingiberis Recens, an important drug of GZD, is particularly scarce.

Based on previous study \[[@B13-ijms-17-01409],[@B14-ijms-17-01409],[@B15-ijms-17-01409]\], the constituents of GZD have been tentatively identified. Furthermore, we have focused on detecting and identifying the compounds absorbed in vivo and metabolites in GZD. Here, SD rats were chosen as the experimental animal. Drug-containing serum and urine samples were obtained. Preparation of GZD was conducted according to a certain ratio. Then, RRLC-Q-TOF-MS was used to detect the prototype compounds and metabolites after oral administration of GZD. The related metabolic investigation of GZD could provide useful information for further study.

2. Results {#sec2-ijms-17-01409}
==========

2.1. Analysis the Constituents of GZD {#sec2dot1-ijms-17-01409}
-------------------------------------

In order to identify the constituents of Guizhi decoction (GZD), the rapid resolution liquid chromatography with quadrupole-time-of-flight mass spectrometry (RRLC-Q-TOF-MS) was used in positive and negative ion modes. Furthermore, the MS data including *t*~R~, values of *m*/*z* and MS/MS data was got from RRLC-Q-TOF-MS analysis. The total ion chromatograms (TICs) of GZD in electrospray ionization (ESI) negative and positive modes are listed in [Figure 1](#ijms-17-01409-f001){ref-type="fig"}.

The structures of most compounds in GZD were tentatively characterized by comparing their TOF-MS data, referring to related literature and comparing reference standards. Finally, a total of 71 compounds including 16 compounds originating from Radix Paeoniae Alba, one from Ramulus Cinnamomi, 33 from Radix Glycyrrhizae, four from Fructus Jujubae and 17 from Rhizoma Zingiberis Recens in GZD were detected by RRLC-Q-TOF-MS in negative or positive ion mode. In addition, 60 compounds of GZD had a known structure, and the others were isomers of part compounds from the explicit structures. The related information about identified components is listed in [Table 1](#ijms-17-01409-t001){ref-type="table"}.

2.2. Analysis of Prototype Compounds in Plasma Sample {#sec2dot2-ijms-17-01409}
-----------------------------------------------------

For the sake of analyzing the prototype components in plasma, we compared the TICs of dosed and blank rat blood. Compared with the normal control group, a total of 15 constituents were identified from rat plasma at dosed group according to their TOF-MS data (*m*/*z*, MS/MS, t~R~ et al.). Among these 15 compounds, there are five compounds originating from Radix Paeoniae Alba (paeoniflorin, albiflorin, epicatechin, catechin and gallic acid), eight from Radix Glycyrrhizae (liquiritin, isoliquiritin, liquritigenin, isoliqurigenin, glycyrrhizic acid, naringenin-5-*O*-glucoside, naringenin-7-*O*-glucoside and formononetin), one from Ramulus Cinnamomi (cinnamic acid) and one from Rhizoma Zingiberis Recens (6-gingerol). The TICs of those 15 compounds and blank rat plasma are shown in [Figure 2](#ijms-17-01409-f002){ref-type="fig"}. In addition, prototype compounds of GZD including its related TOF-MS data can be found in [Table 1](#ijms-17-01409-t001){ref-type="table"}.

2.3. Analysis of Metabolites in Blood and Urine Samples {#sec2dot3-ijms-17-01409}
-------------------------------------------------------

As we know, after intragastric administration of the drug, the compounds originating from the drug were metabolized by intestinal bacteria in the intestine \[[@B16-ijms-17-01409]\]. Then, they were absorbed into plasma so they can be metabolized further by all kinds of drug metabolism enzymes in liver. In principle, there are two metabolic reactions which are called phase I and phase II reactions. Through the phase I reactions including oxidation, reduction, and hydrolysis \[[@B17-ijms-17-01409]\], the prototype components could be converted into aglycone, oxidized aglycone or reduced aglycone. After that, phase II reactions can convert the products of phase I into metabolites. In addition, the phase II reactions were focused on conjugating with glucuronide and sulfate \[[@B18-ijms-17-01409],[@B19-ijms-17-01409],[@B20-ijms-17-01409],[@B21-ijms-17-01409]\]. In order to screen metabolites which were mainly conjugated with glucuronidation and sulfation, we use base peak chromatograms (BPCs) with neutral loss scans of 176 and 80 Da to find compounds existing in the rat plasma ([Figure 3](#ijms-17-01409-f003){ref-type="fig"}a) and urine samples ([Figure 3](#ijms-17-01409-f003){ref-type="fig"}b) in negative mode. A total of 47 peaks were identified which highly promoted the metabolite profiling of GZD. One metabolite was identified in positive mode. Comparing the TICs and, referring to references \[[@B22-ijms-17-01409],[@B23-ijms-17-01409]\], another four metabolites were detected. The results showed that 52 components were tentatively detected as metabolites of GZD. All of the available information about the metabolites is shown in [Table 2](#ijms-17-01409-t002){ref-type="table"} and [Table 3](#ijms-17-01409-t003){ref-type="table"}.

### 2.3.1. Characterization of (epi) Catechin-Related Metabolites {#sec2dot3dot1-ijms-17-01409}

(Epi) catechin-related metabolites are the main metabolic constituents of Radix Paeoniae Alba. Referring to Liang's et al. researches \[[@B24-ijms-17-01409]\] and comparing the mass spectrometry data, 21 constituents altogether were tentatively assigned in rat plasma and urine samples as metabolites, which were derived from (epi) catechin. The details are summarized in [Table 2](#ijms-17-01409-t002){ref-type="table"}. The potential metabolism profile of (epi) catechin-related metabolites is presented in [Figure 4](#ijms-17-01409-f004){ref-type="fig"}.

### 2.3.2. Characterization of Gallic Acid-Related Metabolites {#sec2dot3dot2-ijms-17-01409}

The metabolites of gallic acid-related are also the main metabolites of Radix Paeoniae Alba. By referring to Liang's et al. and Yan's et al. studies \[[@B24-ijms-17-01409],[@B25-ijms-17-01409]\], glucuronidation and sulfation after deglycosylation was the principal metabolic pathway of gallic acid. Ten compounds altogether were identified in animal's plasma and urine samples as metabolites, which were derived from gallic acid. Among them, nine metabolites were characterized as glucuronide conjugates or sulfate conjugates. The available information about gallic acid-related metabolites is presented in [Table 2](#ijms-17-01409-t002){ref-type="table"}, and a proposed metabolic pathway of gallic acid in rat is displayed in [Figure 5](#ijms-17-01409-f005){ref-type="fig"}.

### 2.3.3. Characterization of Flavone-Related Metabolites {#sec2dot3dot3-ijms-17-01409}

The metabolites of flavone-related are the major metabolites from Radix Glycyrrhizae. There are different kinds of complicated flavone components such as naringenin-*O*-glucoside, liquiritigenin and fomononetin existing in GZD. Sixteen compounds altogether were assigned as flavone-related metabolites. Among them, six originated from naringenin-*O*-glucoside-related metabolites, six from liquiritigenin-related metabolites, three from isoliquiritigenin-related metabolites and one from fomononetin-related metabolites. The potential metabolism profile of the main flavone-related metabolites was described as shown in [Figure 6](#ijms-17-01409-f006){ref-type="fig"}, and information about all the flavone-related metabolites is listed in [Table 2](#ijms-17-01409-t002){ref-type="table"}.

### 2.3.4. Characterization of Other Metabolites {#sec2dot3dot4-ijms-17-01409}

Paeoniflorin-related, cinnamic acid-related and gingerol-related compounds were also the most important metabolites of GZD. There are five metabolites belonging to them, among which three originated from paeoniflorin-related metabolites, one from cinnamic acid-related metabolites and one from gingerol-related metabolites. Further details can be seen in [Table 2](#ijms-17-01409-t002){ref-type="table"}.

3. Discussion {#sec3-ijms-17-01409}
=============

In present study, we mainly discussed the identification and detection of (epi) catechin-related, gallic acid-related and flavone-related metabolites as they were found to be significant metabolites with high content in GZD. In addition, other metabolites such as gingerol-related metabolites are briefly introduced.

M1 (*t*~R~ = 4.494 min) showed \[M−H\]^−^ at *m*/*z* 465.0785 in a negative BPC model. The \[aglycon−H\]^−^ at 289.0622 was observed, conforming to a neutral loss of 176 Da (C~6~H~8~O~6~). In addition, the identification of its major fragment ion at *m*/*z* 245.0724 was in line with the related literature \[[@B26-ijms-17-01409]\]. Thus, M1 was preliminary identified as catechin-*O*-glucuronide and its molecular formula was C~21~H~22~O~12~. M2 and M3 displayed \[M−H\]^−^ at *m*/*z* 479.1170 and 479.1208, respectively. Considering the appearance of the same ions at *m*/*z* 303.0860 and 175.0234, M2 and M3 are speculated to be isomers of each other. Furthermore, the loss of 176 Da indicated M2 and M3 were glucuronide conjugates. Compared to M1, catechin-*O*-glucuronide, M2 and M3 had an additional CH~2~ unit according to their high resolution mass spectrometer (HRMS) data, which determined their formula to be C~22~H~24~O~12~. Hence, M2 and M3 were identified as Methyl (epi) catechin conjugating with glucuronide. Following a previously research \[[@B27-ijms-17-01409]\], M2 and M3 were tentatively identified as 3'-*O*-methyl (epi) catechin 5-*O*-glucuronide and 3'-*O*-methyl (epi) catechin 7- or 4'-*O*-glucuronide, respectively. In the same way, another three (epi) catechin-related metabolites conjugating with glucuronide, M4, M6 and M20 were tentatively detected and identified as 5-(3,4-dihydroxyphenyl)-γ-valerolactone glucuronide, 5-(3-methoxyl-4-hydroxyphenyl)-valerolactone glucuronide and benzoyl glucuronide, respectively. M21 (*t*~R~ = 10.089 min) was determined to be C~9~H~9~NO~4~ according to the speculation of the HRMS data, and its displayed \[M−H\]^−^ at *m*/*z* 194.0298. The main fragment ion at *m*/*z* 150.0562 showed a loss of 44 Da which indicated M21 might be an acid. According to a previous report \[[@B28-ijms-17-01409]\], M21 was inferred to be 3-hydroxyhipuric acid. As for the (epi) catechin-related metabolites conjugating with sulfate, the neutral loss of molecular weight was 80 Da. According to this regulation, their HRMS data and related literature \[[@B29-ijms-17-01409],[@B30-ijms-17-01409],[@B31-ijms-17-01409]\], we completely identified 14 compounds which were sulfate conjugates. Altogether, 21 constituents of (epi) catechin-related metabolites were identified in rat blood and urine samples.

M22 displayed \[M−H\]^−^ at *m*/*z* 345.1354, and its ion fragmentation was predominant at *m*/*z* 169.1232 which made clear the elimination of glucuronide residue of M22. Combining with the HRMS data, M22 was considered as gallic acid glucuronide and its molecular formula was C~13~H~14~O~11~. Likewise, the identification of another eight metabolites was carried out, including two glucuronide conjugates (M24 and M28) and six sulfate conjugates (M25, M26, M27, M30 and M31). Isomeric compounds were also examined. For the sake of distinguishing between them, a comparison of their retention times and consultation with previous literature \[[@B25-ijms-17-01409],[@B32-ijms-17-01409]\] was performed. M23 displayed \[M−H\]^−^ at *m*/*z* 183.0887. Coincidently, one of the identified gallic acid-related glucuronide conjugates---M24 (4-*O*-methylgallic acid glucuronide)---showed a main ion fragment at *m*/*z* 183.0944. Moreover, the major ion fragment at *m*/*z* 183.0944 was the \[aglycon−H\]^−^ of M24. Therefore, M23 might be 4-*O*-methylgallic acid. The main fragment ion of M23 at *m*/*z* 139.0268 and 168.0197 confirmed that M23 was 4-*O*-methylgallic acid. In total, there were nine compounds of gallic acid-related metabolites which were tentatively detected.

M36, M37, M38, M39 were chosen as instances to elaborate the process of flavone-related identification. M36 displayed a \[M−H\]^−^ at *m*/*z* 527.0246. M37 and M38 showed the same \[M−H\]^−^ at *m*/*z* 447.1025. M39 showed a \[M−H\]^−^ at *m*/*z* 350.9982. M37 and M38 had the same ion fragments at *m*/*z* 271.0887 and 175.0160, which not only indicated M37 and M38 were isomeric but also confirmed that both of them conjugate with glucuronide. Based on HRMS data and related literature \[[@B25-ijms-17-01409],[@B33-ijms-17-01409]\], M37 and M38 were tentatively identified respective as naringenin-4'-*O*-glucuronide and naringenin-7-*O*-glucuronide, and their molecular formula was C~21~H~20~O~11~. M39 had major MS/MS ions at *m*/*z* 271.0350 and 150.9829, which indicated M39 was a naringenin-related compound. The neutral loss of 80 Da showed that M39 was a sulfate conjugate. Therefore, M39 was tentatively assigned as naringenin-*O*-sulfate. M36 had its main fragment ions at *m*/*z* 447.0951, 351.0192 and 271.0628. This information suggested that M36 was conjugating with both sulfate and glucuronide. In addition, it might be a naringenin-related compound. Therefore, M36 was assigned as naringenin-*O*-glucuronide-*O*-sulfate. Altogether, there were 16 components of flavone-related metabolites which were tentatively identified.

M51 showed \[M+H\]^+^ at *m*/*z* 471.1015. Its major ion fragment was at *m*/*z* 295.0564 implying that M51 might be a compound conjugating glucuronide. Therefore, M51 was tentatively identified as 6-gingerol-*O*-glucuronide. Unfortunately, there are no other gingerol-related even if Rhizoma Zingiberis Recens-related metabolites were detected and identified. Considering there are many components of originated from Rhizoma Zingiberis Recens, the probable reason was that the main components of Rhizoma Zingiberis Recens were hard to metabolize. A previous report deemed that the major components of Rhizoma Zingiberis Recens are volatile oils which are not detectable and retainable with RRLC-Q-TOF-MS analysis \[[@B34-ijms-17-01409]\]. The real reason actually remains unknown.

4. Materials and Methods {#sec4-ijms-17-01409}
========================

4.1. Reagents {#sec4dot1-ijms-17-01409}
-------------

Methanol and formic acid of HPLC grade were obtained from Merck (Darmstadt, Germany). Acetonitrile of HPLC grade was obtained from Fisher Scientific (Pittsburgh, PA, USA). Ultra-high purity water was prepared by Milli-Q system (Millipore, Billerica, MA, USA). All other chemicals were commercially available (Beijing Chemical Works, Beijing, China) and were of analytical reagent (AR) grade.

Radix Paeoniae Alba Ramulus Cinnamomi, Radix Glycyrrhizae, and Fructus Jujubae were obtained from Tong-Ren-Tang drugstore (Beijing, China). Rhizoma Zingiberis Recens was purchased from Dong-Zhi-Men vegetable market (Beijing, China). All of the crude drugs were identified by Chunsheng Liu (Academy of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China). The standards of Paeoniflorin, liquirituin, cinnamic acid, glycyrrhizic acid were got from National Institute for the Control of Pharmaceutical and Biological Products.

4.2. Rapid Resolution Liquid Chromatography with Quadrupole-Time-of-Flight Mass Spectrometry (RRLC-Q-TOF-MS) Analysis {#sec4dot2-ijms-17-01409}
---------------------------------------------------------------------------------------------------------------------

RRLC-MS system is made up of an Agilent 1260 RRLC system coupled with Agilent 6520 Q-TOF mass spectrometer (6520, Aglient Technologies, Santa Clara, CA, USA). Both positive and negative ion modes were operated by an ESI source (6520, Aglient Technologies). Furthermore, full wavelength scanning analysis over an *m*/*z* range of 100--1500 was performed in positive or negative ionization mode. Data acquisition and processing were performed using Mass Hunter Qualitative Analysis B.04.00 software (Aglient Technologies).

The analytical column was operated by an Agilent ZORBAX SB-C18 (2.1 × 50 mm, 1.8 μm). The mobile phase is made up of 0.1% formic acid water (A) and acetonitrile (B). The linear elution gradient was as follows: 0--5 min, 5% B; 5--15 min, 5%--25% B; 15--25 min, 25%--40% B; 25--45 min, 40%--95% B. The injection volume was 2 mL. The flow rate was 0.3 mL/min and column temperature was at 35 °C. The conditions of the mass spectrometer under the ESI mode were as follows: ion spray voltage was 3500 V; N~2~ as drying gas and its flow rate was 10 L/min. The temperature of N~2~ 350 °C; the pressure of nebulizer was 40 spi. The collision energy was set at 20 V in initial and then changed when necessary.

4.3. Preparation of Guizhi Decoction (GZD) {#sec4dot3-ijms-17-01409}
------------------------------------------

To prepare the GZD, the crude drugs---namely, Ramulus Cinnamomi (9 g), Radix Paeoniae Alba (9 g), Radix Glycyrrhizae (6 g), Rhizoma Zingiberis Recens (9 g) and Fructus Jujubae (12 pieces)---were immersed in an eight-fold mass of distilled water for 30 min. After that, the mixture decocted for 30 min and filtered. Subsequently, a six-fold mass of distilled water was added to the mixture and decocted for another 30 min. We were combining the two filtrates and making the concentration of crude drug to 1 g/L.

4.4. Animal Housing Environment and Experiments {#sec4dot4-ijms-17-01409}
-----------------------------------------------

Fourteen healthy male Sprague-Dawley (SD) rats (200 ± 20 g) used in the experiments were purchased from Vital River Laboratory Animal Co., Ltd. (Beijing, China). They were maintained under standard conditions with light cycles of 12 h on and 12 h off. The room temperature and relative humidity were 23 ± 3 °C and 50% ± 10%, respectively. Principles of laboratory animal care and all protocols were in accordance with the relevant national legislation and local guidelines and were approved by Animal Care and Use Committee of the Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences (Date: 6 August 2014; No.: 201408-16).

After 7 days' acclimation in the metabolism cages and 12 h fasting with only water ad libitum, animals were used in experiments and randomly divided into two groups. Rats were orally administrated with GZD (10 mL/kg) once a day for two consecutive days as experimental group in Group 1. Rats were orally administrated with an equivalent volume of distilled water as normal control in Group 2. Then, 24 h urine was collected on the 9th day.

On the 9th day after the final oral administration, all rats were anaesthetized with 4% chloral hydrate, and the blood samples were collected from the portal vein. The animal serum of the same group was combined. The serum samples were obtained by centrifugation of blood at 3500 rpm for 15 min and were kept frozen at −80 °C until necessary.

4.5. Sample Preparation {#sec4dot5-ijms-17-01409}
-----------------------

### 4.5.1. Preparation of GZD {#sec4dot5dot1-ijms-17-01409}

To prepare the test products of GZD, GZD (prepared before, 1 g crude drug per milliliter) of 0.1 mL were placed in 10 mL volumetric flasks, diluted with methanol to volume and filtered with 0.22 µm PTFE membrane.

### 4.5.2. Preparation of Plasma Samples {#sec4dot5dot2-ijms-17-01409}

Two milliliter plasma was spiked with 6 mL methanol by vortex mixing for 30 s. Then, the mixture was immediately centrifuged for 15 min at 3500 rpm and at 4 °C to obtain the supernatant. The supernatant was shifted and evaporated to dryness. Then the residue was dissolved in 1 mL methanol. After that, the reconstituted extraction was centrifuged again for 15 min at 12,000 rpm and at 4 °C. At last, the supernatants were stored at 4 °C until RRLC-Q-TOF-MS analysis.

### 4.5.3. Preparation of Urine Samples {#sec4dot5dot3-ijms-17-01409}

Urine samples were evaporated at 65 °C to dryness. The residues were dissolved in 10 mL methanol, and the reconstituted extraction was centrifuged for 15 min at 3500 rpm and at 4 °C to obtain the supernatant. The supernatant was transferred and evaporated to dryness. Then, the residues were thoroughly dissolved in 5 mL methanol. After that, the mixture was filtered with 0.22 µm PTFE membrane. Finally, the filtrates were stored at 4 °C until RRLC-Q-TOF-MS analysis.

5. Conclusions {#sec5-ijms-17-01409}
==============

In this paper, an efficient RRLC-Q-TOF-MS method was used for separation and identification of absorbed constituents and metabolites in rat blood and urine after gavaging GZD. Altogether, 67 constituents comprising 15 prototype compounds and 52 metabolites were detected and tentatively identified in rat urine and plasma samples. In addition, 71 components altogether originating from GZD were detected or characterized. The results showed that phenolic compounds such as gingerol and shogaol were the main constituents of Rhizoma Zingiberis Recens in GZD. Cinnamic acid was the major compound of Ramulus Cinnamomi in GZD. Both phenolic compounds and cinnamic acid were found to be small polor compounds, which can be quickly absorbed into plasma. This feature indicated that GZD can be used for clinical treatment of exterior syndromes such as common colds and pyretic conditions. The major constituents of Radix Paeoniae Alba, Radix Glycyrrhizae and Fructus Jujubae were flavone and saponin. Most of them were absorbed into plasma and were metabolized by all kinds of metabolism enzymes in liver. After two-phase reaction in the liver, they were metabolized to secondary metabolites, which took effect in vivo. Analysis of metabolites showed that (epi) catechin, gallic acid and flavone were the major sources of metabolites, which originated from metabolism of GZD in vivo. Sulfation and glucuronidation were the main metabolic pathways in the metabolic process of GZD in vivo. This study systematically explored the plasma and urine metabolic profiles of GZD. The results of this study can offer essential data for deeper pharmacological and clinical studies in GZD.
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![Rapid resolution liquid chromatography with quadrupole-time-of-flight mass spectrometry (RRLC-Q-TOF-MS) chromatograms of prepared Guizhi decoction (GZD). (**a**) Total ion chromatograms in negative mode; (**b**) Total ion chromatograms in positive mode.](ijms-17-01409-g001){#ijms-17-01409-f001}

![RRLC-Q-TOF-MS chromatograms of 15 prototype components in dosed and blank rat plasma. (**a**) Total ion chromatogram (TIC) of dosed rat plasma in negative mode; (**b**) TIC of dosed rat plasma in positive mode; (**c**) TIC of blank rat plasma in negative mode; and (**d**) TIC of blank rat plasma in positive mode.](ijms-17-01409-g002){#ijms-17-01409-f002}

![Base peak chromatograms (BPCs) with neutral loss scanning of 176 and 80 Da in negative mode to find constituents existing in (**a**) Rat plasma samples; (**b**) Rat urine samples.](ijms-17-01409-g003){#ijms-17-01409-f003}

![The potential metabolic profile of (epi) catechin-related metabolites.](ijms-17-01409-g004){#ijms-17-01409-f004}

![The potential metabolic profile of gallic acid-related metabolites.](ijms-17-01409-g005){#ijms-17-01409-f005}

![The potential metabolic profile of flavone-related metabolites. (**a**) Naringenin-*O*-glucoside-related metabolites; (**b**) Liquiritigenin-related metabolites; (**c**) Isoliquiritigenin-related metabolites; and (**d**) Formononetin-related metabolite.](ijms-17-01409-g006){#ijms-17-01409-f006}

ijms-17-01409-t001_Table 1

###### 

Identification and detection of chemical compounds of Guizhi decoction (GZD) by rapid resolution liquid chromatography with quadrupole-time-of-flight mass spectrometry (RRLC-Q-TOF-MS).

  No.   *t*~R~ (min)   Identification                                                         Formula               Negative Ion (*m*/*z*)      Positive Ion (*m*/*z*)                   Source                                                             
  ----- -------------- ---------------------------------------------------------------------- --------------------- --------------------------- ---------------------------------------- ------------------------- ---------------------------------------- ----
  A1    0.945          cAMP                                                                   C~10~H~12~N~5~O~6~P   328.0459                    134.0463                                 330.0590                  136.0618                                 ZJ
  A2    1.194          Gallic acid                                                            C~7~H~6~O~5~          169.0133                    125.0239                                 \-                        \-                                       P
  A3    6.804          Epicatechin                                                            C~15~H~14~O~6~        289.0728                    245.0824, 203.0730, 125.0824,109.0306    \-                        \-                                       P
  A4    7.035          Oxypaeoniflorin isomer I                                               C~23~H~28~O~12~       \-                          \-                                       497.1649                  197.0811, 179.0701, 151.0751, 121.0285   P
  A5    7.685          Catechin                                                               C~15~H~14~O~6~        289.0718                    245.0827, 203.0720, 151.0398             291.0858                  207.0669, 179.0705, 147.0432, 139.0388   P
  A6    7.762          Oxypaeoniflorin                                                        C~23~H~28~O~12~       495.1508                    465.1381, 333.0985, 255.0670, 177.0554   \-                        \-                                       P
  A7    10.199         Albiflorin                                                             C~23~H~28~O~11~       525.1630 \[M+HCOO−H\]^−^    121.0294                                 481.1706                  197.0811                                 P
  A8    10.391         Liquiritigenin-7-*O*-glucoside-4'-*O*-apiosyl-*O*-glucoside            C~32~H~40~O~18~       711.2131                    549.1615                                 \-                        \-                                       G
  A9    10.856         Paeoniflorin                                                           C~23~H~28~O~11~       525.1619 \[M+HCOO−H\]^−^    449.1453, 327.1082, 165.0541, 121.0291   \-                        \-                                       P
  A10   11.140         Mudanpioside I                                                         C~23~H~28~O~11~       479.1664                    121.0290                                 481.1703                  179.0709                                 P
  A11   11.405         Oxypaeoniflorin isomer II                                              C~23~H~28~O~12~       495.1513                    137.0243                                 \-                        \-                                       P
  A12   12.305         Naringenin-7-*O*-glucoside                                             C~21~H~22~O~10~       433.1154                    271.0612, 151.0034, 119.0503             \-                        \-                                       G
  A13   12.423         Liquiritigenin-7-*O*-glucoside-4'-*O*-apiosyl-*O*-glucoside isomer I   C~32~H~40~O~18~       711.2131                    549.1615                                 \-                        \-                                       G
  A14   12.704         4-Shogoal                                                              C~15~H~20~O~3~        \-                          \-                                       249.1500                  177.0920, 137.0604                       ZR
  A15   12.710         Liquiritin                                                             C~21~H~22~O~9~        417.1189                    255.0654                                 \-                        \-                                       G
  A16   12.810         Liquiritin-apioside                                                    C~26~H~30~O~13~       549.1589                    255.0662                                 \-                        \-                                       G
  A17   12.825         Rutin                                                                  C~27~H~30~O~16~       609.1451                    301.1452                                 611.1645                  303.0517                                 ZJ
  A18   13.245         Galloylpaeoniflorin                                                    C~30~H~32~O~15~       631.1660                    465.1385, 313.0556, 271.0454             633.1814                  315.0705, 179.0700, 153.0179, 127.0390   P
  A19   13.404         Kaempferol-3-*O*-rutinoside                                            C~27~H~30~O~15~       593.1537                    285.0394                                 595.1698                  287.0563                                 ZJ
  A20   14.277         Galloylpaeoniflorin isomer I                                           C~30~H~32~O~15~       631.1667                    477.0935, 271.0604, 121.0290             \-                        \-                                       P
  A21   14.351         Naringenin-5-*O*-glucoside                                             C~21~H~22~O~10~       433.1154                    271.0609, 151.0032                       \-                        \-                                       G
  A22   14.706         Paeoniflorin isomer I                                                  C~23~H~28~O~11~       525.1630 \[M+HCOO−H\]^−^    121.0291                                 481.1709                  197.0809, 105.0339                       P
  A23   15.056         Lactiflorin                                                            C~23~H~26~O~10~       507.1519 \[M+HCOO−H\]^−^    461.1430, 283.0631, 177.0555, 121.0292   \-                        \-                                       P
  A24   15.400         Lsoliquiritin-apioside                                                 C~26~H~30~O~13~       549.1620                    255.0662                                 \-                        \-                                       G
  A25   15.538         Ononin                                                                 C~22~H~22~O~9~        475.1256 \[M+HCOO−H\]^−^    267.0651, 252.0416                       431.1336                  269.0809                                 G
  A26   15.714         Lsoliquiritin                                                          C~21~H~22~O~9~        417.1150                    225.0659, 135.0086, 119.0500             \-                        \-                                       G
  A27   15.813         5-hydroxylliquiritin                                                   C~21~H~22~O~10~       433.1146                    271.0607                                 \-                        \-                                       G
  A28   16.544         Liquiritigenin                                                         C~15~H~12~O~4~        255.0671                    199.0508, 135.0094                       \-                        \-                                       G
  A29   17.605         10-Gingerdiol                                                          C~21~H~36~O~4~        \-                          \-                                       376.1810                  259.1711, 137.0609                       ZR
  A30   18.112         Licorice saponin G2                                                    C~42~H~62~O~17~       837.3917                    351.0576                                 839.4062                  663.3724, 469.3306                       G
  A31   18.125         8-Gingerdione                                                          C~19~H~28~O~4~        \-                          \-                                       321.2217                  177.0923, 137.0604                       ZR
  A32   18.638         Pentagalloylglucose                                                    C~41~H~32~O~26~       939.1109                    \-                                       \-                        \-                                       P
  A33   18.679         10-Gingerol                                                            C~21~H~34~O~4~        \-                          \-                                       373.1668 \[M+Na\]^+^      351.2658, 207.1017, 177.0557, 137.0605   ZR
  A34   18.781         Benzoylpaeoniflorin                                                    C~41~H~32~O~26~       629.1876, \[M+HCOO−H\]^−^   553.1716, 431.1349, 165.0558, 121.0291   \-                        \-                                       P
  A35   18.977         Apioglycyrrhizin                                                       C~42~H~62~O~16~       821.3949                    \-                                       \-                        \-                                       G
  A36   19.334         Benzoylpaeoniflorin isomer                                             C~30~H~32~O~12~       629.1881 \[M+HCOO−H\]^−^    121.0293                                 607.1770 \[M+Na\]^+^      319.1183, 267.0860, 197.0808, 151.0340   P
  A37   19.542         Licorice saponin A3                                                    C~48~H~72~O~21~       983.4484                    821.3958, 351.0559                       985.4642                  809.4310, 615.3888, 453.3359             G
  A38   20.278         Acetoxyglycyrrhizin acid                                               C~44~H~64~O~18~       \-                          \-                                       881.4165                  705.3835, 511.3421                       G
  A39   20.503         Licorice saponin G2 isomer I                                           C~42~H~62~O~17~       837.3904                    \-                                       839.4058                  663.3730, 469.3310                       G
  A40   21.153         8-Gingerdiol                                                           C~19~H~32~O~4~        \-                          \-                                       326.1860                  137.0605                                 ZR
  A41   21.354         Formononetin                                                           C~16~H~12~O~4~        267.0661                    252.0415, 223.5401                       269.0806                  254.0850, 225.0557                       G
  A42   21.510         Isoliquiritigenin                                                      C~15~H~12~O~4~        255.0671                    135.0094, 119.0498                       \-                        \-                                       G
  A43   21.767         Licorice saponin E2                                                    C~42~H~60~O~16~       819.3816                    351.0548                                 \-                        \-                                       G
  A44   21.960         Licorice saponin G2 isomer II                                          C~42~H~62~O~17~       837.3907                    \-                                       839.4058                  645.3617, 469.3312, 451.3203             G
  A45   22.636         Licorice saponin G2 isomer III                                         C~42~H~62~O~17~       \-                          \-                                       839.4060                  487.3406, 469.3307, 451.3193             G
  A46   22.636         22β-Acetoxyllicoricesaponin C2                                         C~44~H~64~O~17~       863.4066                    \-                                       865.4217                  495.3466                                 G
  A47   23.051         Licorice saponin G2 isomer IV                                          C~44~H~62~O~17~       837.3918                    \-                                       839.4069                  487.3415, 469.3307, 451.3215             G
  A48   23.182         6-Paradol                                                              C~17~H~26~O~3~        \-                          \-                                       279.1969                  177.0940, 163.0755, 145.0661, 137.0601   ZR
  A49   23.182         8-Dehydrogingerdione                                                   C~19~H~26~O~4~        \-                          \-                                       319.1886                  177.0916, 163.0751, 145.0659, 137.0604   ZR
  A50   23.208         6-Gingerdiol                                                           C~17~H~28~O~4~        \-                          \-                                       297.2057                  177.0923, 163.0752, 137.0595             ZR
  A51   23.416         Glycyrrhizic acid                                                      C~42~H~62~O~16~       821.3952                    \-                                       823.4109                  647.3780, 453.3368                       G
  A52   23.935         Licorice saponin G2 isomer IV                                          C~42~H~62~O~17~       \-                          \-                                       839.4046                  487.3423, 469.3307, 451.3203             G
  A53   23.961         6-Gingerol                                                             C~17~H~26~O~4~        \-                          \-                                       295.1916                  163.0757, 137.0605                       ZR
  A54   24.117         Uralenol                                                               C~20~H~18~O~7~        369.1353                    229.0864, 139.0395                       371.1493                  315.0874, 175.0398                       G
  A55   24.403         6-Shogaol                                                              C~17~H~24~O~3~        \-                          \-                                       277.1790                  177.0675, 145.0647, 137.0598             ZR
  A56   24.482         LS-K2                                                                  C~42~H~62~O~16~       821.3942                    \-                                       823.4411                  647.3785, 453.3361                       G
  A57   24.664         Apioglycyrrhizin                                                       C~42~H~62~O~16~       821.3949                    \-                                       823.4111                  647.3780, 453.3362                       G
  A58   24.755         6-Gingerdione                                                          C~17~H~24~O~4~        \-                          \-                                       293.1773                  177.0557, 145.0295, 137.0604             ZR
  A59   25.756         LS-J2                                                                  C~42~H~64~O~16~       823.4130                    351.0554                                 825.4303                  453.3377                                 G
  A60   26.458         LS-C2                                                                  C~42~H~62~O~15~       805.4300                    351.0565                                 825.4300 \[M+H2O+H\]^+^   437.3435, 353.0731                       G
  A61   26.640         10-Gingerdione                                                         C~21~H~32~O~4~        \-                          \-                                       349.1784                  177.0917, 137.0591                       ZR
  A62   26.718         Glycycoumarin                                                          C~21~H~20~O~6~        367.1184                    309.0402, 297.0405                       369.1335                  313.0725, 285.0769                       G
  A63   27.472         7-Shogaol                                                              C~18~H~26~O~3~        \-                          \-                                       291.1974                  177.0918, 137.0606                       ZR
  A64   28.278         Licoricone                                                             C~22~H~22~O~6~        381.1340                    351.0869, 323.0593                       383.1508                  327.0872, 299.0934                       G
  A65   28.954         10-Dehydrogingerdione                                                  C~21~H~30~O~4~        \-                          \-                                       347.2188                  177.0835, 137.0611                       ZR
  A66   29.344         Isoglycyrol                                                            C~21~H~18~O~6~        365.1039                    307.0247, 295.0247                       367.1265                  339.1254, 311.0562                       G
  A67   30.020         8-Shogaol                                                              C~19~H~28~O~3~        \-                          \-                                       305.2118                  177.0921, 137.0604                       ZR
  A68   30.020         8-Gingerol                                                             C~19~H~30~O~4~        \-                          \-                                       345.2042                  177.0908, 137.0596                       ZR
  A69   33.791         10-Shogaol                                                             C~21~H~32~O~3~        \-                          \-                                       333.2431                  177.0910, 137.0595                       ZR
  A70   34.519         Cinnamic acid                                                          C~9~H~8~O~2~          \-                          \-                                       149.0235                  121.0283                                 C
  A71   38.121         Oleanolic acid                                                         C~30~H~38~O~3~        455.3533                    \-                                       \-                        \-                                       ZJ

Note: *t*~R~ (min): Retention time; P: Radix Paeoniae Alba; G: Radix Glycyrrhizae; C: Ramulus Cinnamomi; ZJ: Fructus Jujubae and Rhizoma; ZR: Zingiberis Recens; -: Not existed.

ijms-17-01409-t002_Table 2

###### 

Identification and detection of metabolites of GZD in rat plasma and urine samples by RRLC-Q-TOF-MS.

  No.   *t*~R~ (min)   Identification                                             Formula            Urine   Plasma   Negative Ion (*m*/*z*)   Possible Original Compound     Source                              
  ----- -------------- ---------------------------------------------------------- ------------------ ------- -------- ------------------------ ------------------------------ ----------------------------------- ---
  M1    4.494          Catechin-*O*-glucuronide                                   C~21~H~22~O~12~    \+      \-       465.0785                 289.0622, 245.0724             (Epi) catechin-related              P
  M2    9.026          3'-*O*-Methyl (epi)catechin 5-*O*-glucuronide              C~21~H~24~O~12~    \+      \-       479.0965                 303.0976, 175.0176             (Epi) catechin-related              P
  M3    10.220         3'-*O*-Methyl (epi)catechin 7- or 4'-*O*-glucuronide       C~21~H~24~O~12~    \-      \+       479.0948                 303.0876, 175.0242             (Epi) catechin-related              P
  M4    8.861          5-(3,4-Dihydroxyphenyl)-γ-valerolactone glucuronide        C~17~H~20~O~10~    \+      \-       383.0757                 207.0587, 163.0691             (Epi) catechin-related              P
  M5    5.949          5-(3,4-Dihydroxyphenyl)-γ-valerolactone sulfate            C~11~H~12~O~7~S    \+      \-       287.0027                 207.0580, 163.0685             (Epi) catechin-related              P
  M6    17.003         5-(3-Methoxyl-4-hydroxyphenyl)-valerolactone glucuronide   C~18~H~22~O~10~    \+      \-       397.0907                 221.0719                       (Epi) catechin-related              P
  M7    19.489         5-(3-Methoxyl-4-hydroxyphenyl)-valerolactone sulfate       C~12~H~14~O~7~S    \+      \-       301.0187                 221.0739, 206.0503             (Epi) catechin-related              P
  M8    9.305          5-(3-Hydroxyphenyl)-γ-valerolactone sulfate                C~11~H~12~O~6~S    \+      \-       271.0092                 191.0624                       (Epi) catechin-related              P
  M9    4.276          4-Hydroxy phenylpropionic acid sulfate                     C~9~H~10~O~6~S     \+      \-       244.9955                 165.0596                       (Epi) catechin-related              P
  M10   9.549          3-Hydroxy phenylpropionic acid sulfate                     C~9~H~10~O~6~S     \+      \-       245.0320                 165.0846                       (Epi) catechin-related              P
  M11   8.547          3,4-Dihydroxy phenylpropionic acid sulfate                 C~9~H~10~O~7~S     \+      \-       260.9888                 181.0409, 166.0193             (Epi) catechin-related              P
  M12   2.022          3-Hydroxy-4-methoxy-phenylpropionic acid sulfate           C~10~H~12~O~7~S    \+      \-       275.0040                 195.0717                       (Epi) catechin-related              P
  M13   5.027          3-Methoxy-4-hydroxy-phenylpropionic acid sulfate           C~10~H~12~O~7~S    \+      \+       275.0042                 195.0504                       (Epi) catechin-related              P
  M14   4.511          *m*-Coumaric acid sulfate                                  C~9~H~8~O~6~S      \+      \-       242.9793                 163.0324                       (Epi) catechin-related              P
  M15   14.077         *p*-Coumaric acid sulfate                                  C~9~H~8~O~6~S      \+      \-       243.0173                 163.0694                       (Epi) catechin-related              P
  M16   10.666         Ferulic acid sulfate                                       C~10~H~10~O~7~S    \+      \+       273.0259                 193.0845                       (Epi) catechin-related              P
  M17   9.057          3-Hydroxy-4-methoxyphenylacetic acid sulfate               C~9~H~10~O~7~S     \+      \-       261.0254                 181.0718                       (Epi) catechin-related              P
  M18   1.661          3,4-Dihydroxy phenylacetic acid sulfate                    C~8~H~8~O~7~S      \+      \-       247.0111                 167.0575                       (Epi) catechin-related              P
  M19   1.713          Protocatechuic acid-3- or -4-*O*-sulfate                   C~7~H~6~O~7~S      \+      \-       232.9967                 153.0423                       (Epi) catechin-related              P
  M20   20.086         Benzoyl glucuronide                                        C~13~H~14~O~8~     \+      \-       297.0939                 121.0658                       (Epi) catechin-related              P
  M21   9.92           3-Hydroxyhipuric acid                                      C~9~H~9~NO~4~      \+      \-       194.0298                 150.0462                       (Epi) catechin-related              P
  M22   13.393         Gallic acid glucuronide                                    C~13~H~14~O~11~    \+      \+       345.1354                 169.1232                       Gallic acid-related                 P
  M23   17.521         4-*O*-Methylgallic acid                                    C~8~H~8~O~5~       \+      \-       183.0887                 168.0197, 139.0268             Gallic acid-related                 P
  M24   14.378         4-*O*-Methylgallic acid glucuronide                        C~14~H~16~O~11~    \+      \-       359.1115                 191.0628, 183.0944             Gallic acid-related                 P
  M25   1.202          2-Deoxy-pyrogallol-1-*O*-sulfate                           C~6~H~6~O~5~S      \+      \-       188.9718                 125.0010, 109.0087             Gallic acid-related                 P
  M26   0.845          Pyrogallol-2-*O*-sulfate                                   C~6~H~6~O~6~S      \+      \-       204.9665                 125.0126                       Gallic acid-related                 P
  M27   1.254          Pyrogallol-1-*O*-sulfate                                   C~6~H~6~O~6~S      \+      \-       204.9665                 124.9982                       Gallic acid-related                 P
  M28   30.462         2-*O*-Methylpyrogallol glucuronide                         C~13~H~16~O~9~     \+      \-       315.2336                 171.1027, 139.1119             Gallic acid-related                 P
  M29   0.888          2-*O*-Methylpyrogallol sulfate                             C~7~H~8~O~6~S      \+      \-       218.9790                 139.0419, 124.0168             Gallic acid-related                 P
  M30   1.228          1-*O*-Methylpyrogallol-3-*O*-sulfate                       C~7~H~8~O~6~S      \+      \-       218.9809                 139.0277                       Gallic acid-related                 P
  M31   2.021          1-*O*-Methylpyrogallol-2-*O*-sulfate                       C~7~H~8~O~6~S      \+      \-       218.9809                 139.0273                       Gallic acid-related                 P
  M32   17.146         Paeonimetabolin I glucuronide isomer I or II               C~16~H~22~O~10~    \+      \-       373.1311                 197.1181                       Paeoniflorin-related                P
  M33   8.939          C~10~H~14~O~3~ sulfate                                     C~10~H~14~O~6~S    \+      \-       260.9913                 181.0443                       Paeoniflorin-related                P
  M34   14.952         C~10~H~18~O~2~ glucuronide                                 C~16~H~26~O~8~     \+      \-       345.1354                 169.1223                       Paeoniflorin-related                P
  M35   19.135         Naringenin                                                 C~15~H~12~O~5~     \+      \-       271.0419                 151.0032                       Naringenin-*O*-glucoside -related   G
  M36   16.194         Naringenin-*O*-glucuronide-*O*-sulfate                     C~21~H~20~O~14~S   \+      \-       527.0264                 447.0951, 351.0192, 271.0628   Naringenin-*O*-glucoside-related    G
  M37   15.292         Naringenin-4'-*O*-glucuronide                              C~21~H~20~O~11~    \+      \-       447.1025                 271.0887, 175.0160             Naringenin-*O*-glucoside-related    G
  M38   17.312         Naringenin-7-*O*-glucuronide                               C~21~H~20~O~11~    \+      \-       447.1025                 271.0887, 175.0160, 150.9851   Naringenin-*O*-glucoside-related    G
  M39   13.133         Naringenin-*O*-sulfate                                     C~15~H~12~O~8~S    \+      \-       350.9982                 271.0390, 150.9829             Naringenin-*O*-glucoside-related    G
  M40   16.690         Liquiritigenin-*O*-glucuronide-*O*-sulfate                 C~21~H~20~O~13~S   \+      \-       511.0306                 431.0900, 335.0135             Liquiritigenin-related              G
  M41   13.386         7,4'-Dihydroxyflavone-*O*-sulfate                          C~15~H~10~O~7~S    \+      \-       332.9885                 253.0431                       Liquiritigenin-related              G
  M42   13.619         Liquiritigenin-4'-*O*-sulfate                              C~15~H~12~O~7~S    \+      \-       335.0018                 255.0569, 134.9995             Liquiritigenin-related              G
  M43   14.230         Liquiritigenin-7-*O*-sulfate                               C~15~H~12~O~7~S    \+      \-       335.0018                 255.0658, 135.0088             Liquiritigenin-related              G
  M44   12.532         Liquiritigenin-4'-*O*-glucuronide                          C~21~H~20~O~10~    \+      \-       431.0754                 255.0498, 113.0137             Liquiritigenin-related              G
  M45   12.924         Liquiritigenin-7-*O*-glucuronide                           C~21~H~20~O~10~    \+      \-       431.0754                 255.0499, 113.0132             Liquiritigenin-related              G
  M46   29.631         Isoliquiritigenin-*O*-sulfate                              C~15~H~12~O~7~S    \+      \-       335.2224                 255.2111                       Isoliquiritigenin-related           G
  M47   16.023         Isoliquiritigenin-4'-*O*-glucuronide                       C~21~H~20~O~10~    \+      \+       431.0754                 255.0672, 113.0247             Isoliquiritigenin-related           G
  M48   16.441         Isoliquiritigenin-7-*O*-glucuronide                        C~21~H~20~O~10~    \+      \-       431.0754                 255.0559, 113.0163             Isoliquiritigenin-related           G
  M42   13.619         Liquiritigenin-4'-*O*-sulfate                              C~15~H~12~O~7~S    \+      \-       335.0018                 255.0569, 134.9995             Liquiritigenin-related              G
  M43   14.230         Liquiritigenin-7-*O*-sulfate                               C~15~H~12~O~7~S    \+      \-       335.0018                 255.0658, 135.0088             Liquiritigenin-related              G
  M44   12.532         Liquiritigenin-4'-*O*-glucuronide                          C~21~H~20~O~10~    \+      \-       431.0754                 255.0498, 113.0137             Liquiritigenin-related              G
  M45   12.924         Liquiritigenin-7-*O*-glucuronide                           C~21~H~20~O~10~    \+      \-       431.0754                 255.0499, 113.0132             Liquiritigenin-related              G
  M46   29.631         Isoliquiritigenin-*O*-sulfate                              C~15~H~12~O~7~S    \+      \-       335.2224                 255.2111                       Isoliquiritigenin-related           G
  M47   16.023         Isoliquiritigenin-4'-*O*-glucuronide                       C~21~H~20~O~10~    \+      \+       431.0754                 255.0672, 113.0247             Isoliquiritigenin-related           G
  M48   16.441         Isoliquiritigenin-7-*O*-glucuronide                        C~21~H~20~O~10~    \+      \-       431.0754                 255.0559, 113.0163             Isoliquiritigenin-related           G
  M49   18.463         Fomononetin-*O*-sulfate                                    C~16~H~12~O~7~S    \+      \-       347.0012                 267.0637                       Fomononetin-related                 G

Note: *t*~R~ (min): Retention time; P: Radix Paeoniae Alba; G: Radix Glycyrrhizae; C: Ramulus Cinnamomi; ZR: Zingiberis Recens; +: Detected; -: Not detected.

ijms-17-01409-t003_Table 3

###### 

[Table 2](#ijms-17-01409-t002){ref-type="table"} supplementary.

  No.   *t*~R~ (min)   Identification               Formula           Urine   Plasma   Positive Ion (*m/z*)   Possible Original Compound   Source                   
  ----- -------------- ---------------------------- ----------------- ------- -------- ---------------------- ---------------------------- ------------------------ ----
  M50   34.133         Glycyrrhetinic acid          C~30~H~46~O~4~    \+      \+       471.3544               317.2164                     Glycyrrhizin-related     G
  M51   23.150         6-Gingerol-*O*-glucuronide   C~23~H~34~O~10~   \+      \-       471.1015               295.0564                     6-Gingerol-related       ZR
  M52   0.524          Hippuric acid                C~9~H~8~NO~3~     \+      \+       178.1015               \-                           Cinnammic acid-related   C

Note: *t*~R~ (min): retention time; G: Radix Glycyrrhizae; C: Ramulus Cinnamomi; ZR: Zingiberis Recens; +: Detected; -: Not detected.
